Deep learning-based strain echocardiography adds prognostic value in heart failure with reduced ejection fraction

European Heart Journal - Imaging Methods and Practice

26 October 2026
Organised by: Logo
ESC Journals ARRHYTHMIAS AND DEVICE THERAPY HEART FAILURE Chronic Heart Failure IMAGING Echocardiography

Abstract

AbstractAims

Echocardiographic global longitudinal strain (GLS) and mechanical dispersion (MD) improve risk prediction in heart failure (HF). To facilitate clinical implementation, we aimed to develop a deep learning (DL)-based method for fast, fully automated GLS and MD and validate its ability to predict ventricular arrhythmia (VA) and all-cause mortality.

Methods and results

This prospective observational study included 568 patients (73 ± 13 years, 67% male) with first diagnosis of HF and reduced ejection fraction (HFrEF). A DL-based method was designed to measure echocardiographic GLS and MD. The median follow-up was 4.8 years (interquartile range: 2.9, 6.1 years). VA occurred in 49 patients (9%), while 118 patients (21%) died. The optimal cut-off values for GLS and MD were 9% and 70 ms. Patients with both impaired GLS and increased MD were at high risk of VA [hazard ratio (HR) 6.98, 95% confidence interval (CI): 3.23–15.1] compared to those with either impaired GLS or increased MD alone [HR 2.84 (95% CI: 1.38–5.86), P < 0.001]. GLS and MD were independently associated with VA and provided potential incremental prognostic value beyond ejection fraction. Feasibility of DL measurements was high (96%), with processing time of 6.4 ± 2.5 s per echocardiogram.

Conclusion

A novel DL-based method for fully automated GLS and MD was feasible, fast, and predicted VA in patients with HFrEF. Combining GLS and MD provided potential incremental prognostic value beyond GLS, MD, or EF alone. This approach may enhance workflow and facilitate arrhythmic risk stratification. Further studies are needed to determine whether it can improve selection of patients for ICD therapy.

Trial registration

NCT02286908 at clinicaltrials.gov.

Contributors

Bjørnar Grenne
Bjørnar Grenne

Author

St Olavs Hospital Trondheim , Norway

Thor Edvardsen
Thor Edvardsen

Author

Oslo University Hospital Rikshospitalet Oslo , Norway